Severe hepatic complications of antituberculous therapy

Canadian Journal of Infectious Diseases

Volumn 10, Issue 2, 1999, Pages 167-169

  Turner, Mark O ^a,b   Kevin Elwood, R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

Chemoprophylaxis; Hepatotoxicity; Isoniazid; Liver transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; ISONIAZID; LIVER ENZYME; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CASE REPORT; CHEMOPROPHYLAXIS; CLINICAL PROTOCOL; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; PATIENT MONITORING; RISK BENEFIT ANALYSIS; TUBERCULOSIS;

EID: 2442725203     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/342613     Document Type: Article

References (12)

1. Sharer L, Smith JP. Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid. Ann Intern Med 1969;71:1113-20.
2. Schaberg T, Rebhan K, Lode H. Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respir J 1996;9:2026-30.
3. Steele MA, Burk RF, DesPrez RM. Toxic hepatitis with isoniazid and rifampin: a meta-analysis. Chest 1991;99:465-71.
4. Lee WM. Drug induced hepatotoxicity. N Engl J Med 1995;333:1118-27.
5. Ormerod LP, Skinner C, Wales J. Hepatotoxicity of antituberculosis drugs. Thorax 1996;51:111-3.
6. Van den Brande P, Van Steenbergen W, Vervoort G, Demedts M. Aging and hepatotoxicity of isoniazid and rifampin in pulmonary tuberculosis. Am J Respir Crit Care Med 1995;152:1705-8.
7. Mitchell I, Wendon J, Fitt S, Williams R. Anti-tuberculous therapy and acute liver failure. Lancet 1995;345:555-6.
8. Kopanoff DE, Snyder DE, Caras GJ. Isoniazid-related hepatitis. A US Public Health Service Cooperative Surveillance Study. Am Rev Respir Dis 1978;117:991-1001.
9. Dossing M, Wilcke JTR, Askgaard DS, Nybo B. Liver injury during antituberculosis treatment: an 11-year study. Tubercle Lung Dis 1996;77:335-40.
10. Ormerod LP, for Joint Tuberculosis Committee. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations of the Joint Tuberculosis Committee of the British Thoracic Society. Thorax 1990;45:403-8.
11. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:1359-74.
12. Thompson NP, Caplin ME, Hamilton MI, et al. Antituberculosis medication and the liver: dangers and recommendations in management. Eur Respir J 1995;8:1384-8.